You have read all your free articles, to continue reading subscribe to read the rest of this content.
Cantargia, a private biopharmaceutical company developing therapeutics for the treatment of leukemia has announced the conclusion of the first step in their financial plan and reinforces the board. Sven Andréasson has been appointed as chairman of the board. Sven Andréasson has extensive experiAlready a subscriber Login You have read all…
Surviving an episode of cancer as a teenager set Lao Saal on a path to seek out better ways to detect, monitor and treat the deadly cells. That determination drove him to earn medical and doctoral degrees at Columbia University College of Physicians and Surgeons in New York City in 200Already a subscriber Login You have read all your free…
In the EIT Health funded project Radiobotics is developing a product for automatic analysis of radiographs of the hip. Six European startups in biotech, medtech and digital health will receive in total €180 000 in funding to access samples and collaborate with European biobanks and quality regiAlready a subscriber Login…
Index Pharmaceuticals has announced the closing of a USD 20 million / EUR 15 million new rights issue. The Swedish biotechnology company expects to report data from a Phase III study with its lead product candidate Kappaproct, which is being developed for the treatment of severe Ulcerative ColAlready a subscriber Login You have…
